RT Journal Article
SR Electronic
T1 The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000413
DO 10.1136/jitc-2019-000413
VO 8
IS 1
A1 Peluso, Marisa O
A1 Adam, Ammar
A1 Armet, Caroline M
A1 Zhang, Li
A1 O’Connor, Rachel W
A1 Lee, Benjamin H
A1 Lake, Andrew C
A1 Normant, Emmanuel
A1 Chappel, Scott C
A1 Hill, Jonathan A
A1 Palombella, Vito J
A1 Holland, Pamela M
A1 Paterson, Alison M
YR 2020
UL http://jitc.bmj.com/content/8/1/e000413.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.